IL6 and COVID-19: The role of ∝2-M in COVID-19 has been proposed based on its versatility; specifically, in its tetrameric form, it is able to inhibit all four classes of proteases, while in its dimeric form, it shows increased interaction with mediators of inflammation, such as TNF-∝, Il-2, and IL-6.